xin wang

During ten years of clinical practice and clinical research, she awarded the FIRST PRIZE of EXCELLENT PAPER in annual national neuroscience meeting. In Japan for her PhD degree in Medical Science. She was the first one who discovered the cDNA sequence of BAALC1-6-8 in mammal, an biomarker for acure leukemia related to stem cell differentiation, Xin was the first one who studied BAALC1-6-8 this gene at molecular and cellular biology level. During her postdoc training in National Cancer Institute of NIH in US, she studied a genetic mutated mouse model that die from cardiovascular dysfunction in embryonic development. This publication had been pointed as "must read" by Faculty 1000. As a primary author, her project summary about tumor microenvironment gained "Minority Scholar Award" in AACR meeting. Xin founded her ACURE biotech company to develop and discover therapeutic products to improve human health and expend life span with high quality of daily life. Recently, her company developed a new animal model for angiogenesis study (http://medcraveonline.com/JMEN/JMEN-01-00024.pdf). She is currently developing another animal model for pulmonary and cardiovascular diseases caused by smoke or air pollution (http://clinicalmicrobiology2014.conferenceseries.net).